Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Emerald Health Therapeutics Inc (EMH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9363
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportunity for use as therapeutic alternatives to a multitude of conventional pharmaceutical medicines. The company also provides pharmaceutical research and development, clinical development, clinical research, house extraction, GMP production practices, regulatory approval processes and others. Emerald Health is headquartered in Victoria, British Columbia, Canada.

Emerald Health Therapeutics Inc (EMH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
VivaCell Biotech Enters into Agreement with Emerald Health Pharma 10
Equity Offering 11
Emerald Health Therapeutics Raises USD14.4 Million in Private Placement of Units 11
Emerald Health Therapeutics Raises USD12 Million in Private Placement of Units 12
Emerald Health Therapeutics Raises USD7.1 Million in Private Placement of Shares up on Exercise of Warrants 13
Emerald Health Therapeutics Raises USD13.5 Million in Private Placement of Shares up on Exercise of Warrants 14
Emerald Health Therapeutics Raises USD18.2 Million in Public Offering of Units 15
Emerald Health Therapeutics Raises USD10.6 Million Public Offering of Shares 16
Emerald Health Therapeutics Raises USD2.3 Million in Private Placement of Units 17
Emerald Health Therapeutics Raises USD0.6 Million in Private Placement of Units 18
Acquisition 19
Medna Acquires 45% Stake in T-Bird Pharma for USD4.2 Million 19
Emerald Health Therapeutics Inc – Key Competitors 20
Emerald Health Therapeutics Inc – Key Employees 21
Emerald Health Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 30, 2018: Emerald Health Therapeutics reports 2nd quarter 2018 financial results and provides corporate update 23
May 29, 2018: Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update 25
Apr 02, 2018: Emerald Health Therapeutics Reports 2017 Financial Results and Provides Corporate Update 28
Corporate Communications 30
Oct 11, 2018: Emerald Health Therapeutics Promotes Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing 30
Nov 20, 2017: Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance 31
Oct 02, 2017: Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO 32
Jun 14, 2017: Emerald Health Therapeutics Announces Advisory Board; Plans Clinical Research 33
Product News 34
Apr 17, 2018: Emerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy Stores 34
Other Significant Developments 36
Jul 06, 2017: Emerald Health Provides Corporate Update 36
Feb 22, 2017: Emerald provides corporate update & lays out 2017 growth initiatives 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Emerald Health Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
VivaCell Biotech Enters into Agreement with Emerald Health Pharma 10
Emerald Health Therapeutics Raises USD14.4 Million in Private Placement of Units 11
Emerald Health Therapeutics Raises USD12 Million in Private Placement of Units 12
Emerald Health Therapeutics Raises USD7.1 Million in Private Placement of Shares up on Exercise of Warrants 13
Emerald Health Therapeutics Raises USD13.5 Million in Private Placement of Shares up on Exercise of Warrants 14
Emerald Health Therapeutics Raises USD18.2 Million in Public Offering of Units 15
Emerald Health Therapeutics Raises USD10.6 Million Public Offering of Shares 16
Emerald Health Therapeutics Raises USD2.3 Million in Private Placement of Units 17
Emerald Health Therapeutics Raises USD0.6 Million in Private Placement of Units 18
Medna Acquires 45% Stake in T-Bird Pharma for USD4.2 Million 19
Emerald Health Therapeutics Inc, Key Competitors 20
Emerald Health Therapeutics Inc, Key Employees 21
Emerald Health Therapeutics Inc, Subsidiaries 22

List of Figures
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Emerald Health Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Addex Therapeutics Ltd (ADXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company’s product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson’s disease levodopa-induced dy …
  • Taubman Centers Inc:企業の戦略的SWOT分析
    Taubman Centers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析
    Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Octapharma AG:企業の戦略・SWOT・財務分析
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zen Technologies Limited
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PPL Corp:企業の発電所・SWOT分析2018
    PPL Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executive …
  • Unigroup Inc
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biomm SA (BIOM3):企業の財務・戦略的SWOT分析
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Pharmsynthez (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmsynthez is a pharmaceutical company that manufactures and markets generic active pharmaceutical ingredients. The company offers production and sales of both officinal medicines (original OM) and active pharmaceutical ingredients (API). It offers drugs such as vazostenon, glaumax, cathal …
  • Land Bank of Taiwan Co., Ltd:企業の戦略・SWOT・財務情報
    Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Synergy:企業の戦略・SWOT・財務情報
    Synergy - Strategy, SWOT and Corporate Finance Report Summary Synergy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Arcadia Group Limited:企業の戦略・SWOT・財務分析
    Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Invion Ltd (IVX)-製薬・医療分野:企業M&A・提携分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta blocker for inflammatory …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆